Dongjin Semichem (005290): Where It Stands — 2026-09-25 Deep Dive

2026-09-25 · semiconductor · Dongjin Semichem data page

As of 2026-09-23 (Seoul close). Live numbers on the Dongjin Semichem data page.

Market Action and Technical Positioning

Dongjin Semichem (KRX 005290) posted a sharp gain of 8.57% on September 23, 2026, closing at ₩46,850. The move represented decisive outperformance against the broader Korean indices, with the KOSPI rising 1.04% and the KOSDAQ gaining 0.98%.

Trading activity was supported by synchronized institutional and offshore demand: foreign investors purchased a net 101,869 shares, while domestic institutions absorbed a net 66,900 shares during the session.

Today’s advance accelerates a short-term recovery. Over the past five trading days, the stock has gained 15.39%, extending its 20-day return to +10.63%. Despite this recent rebound, Dongjin Semichem has modestly lagged its domestic peers over the one-month horizon, as the median 20-day return across covered Korean semiconductor names stands at +14.64%. On a medium-term basis, the stock remains in recovery mode, carrying a 60-day return of -16.49%.

From a technical perspective, today’s close at ₩46,850 clears key moving averages that previously acted as resistance. The stock now sits well above both its 20-day moving average (₩41,610) and its 60-day moving average (₩42,780). Within its 52-week trading corridor of ₩31,600 to ₩66,000, Dongjin trades at the 44.3% mark of the range, indicating that while immediate downside momentum has broken, the stock remains well below its prior cyclical peaks.

Fundamental and Operational Drivers

Dongjin Semichem’s operational leverage is tied to wafer starts and advanced packaging activity at its primary domestic clients, Samsung Electronics and SK Hynix. The recent share-price firming coincides with several company-specific operational realities:

1. Photolithography and Etch Chemistry Exposure: Dongjin is the primary domestic producer of KrF and ArF immersion (ArFi) photoresists, alongside anti-reflective coatings (BARC) and ultra-pure process chemicals (such as sulfuric acid and thinners). As memory manufacturers ramp production of high-layer 3D NAND (exceeding 200 to 300 layers) and high-density DRAM nodes, total photolithography steps and wet-chemical consumption increase per wafer, directly benefiting Dongjin’s core electronic materials volume.
2. EUV and Advanced Node Localization: Following South Korea’s supply-chain localization push that accelerated after 2019, Dongjin has worked to qualify extreme ultraviolet (EUV) photoresist and high-selectivity etching chemicals. While ArFi and KrF materials remain the dominant revenue drivers within the photoresist portfolio, progress in advanced node qualification provides high-margin optionality as leading-edge nodes scale.
3. Overseas Capacity and Fab Alignment: Dongjin’s multi-year capital deployment—notably its manufacturing subsidiary in Texas established to supply process chemicals to Samsung’s U.S. fab network—aligns the company with long-term geographic diversification, keeping market attention focused on capacity utilization ramps across late 2026.

The dual inflow from institutional (+66,900 shares) and foreign (+101,869 shares) accounts suggests that market participants are treating the stock’s prior 60-day contraction (-16.49%) as an entry point to capture operating leverage tied to wafer runs.

Risks and Caveats

• Memory Utilization Volatility: Dongjin’s electronic materials division relies heavily on wafer run rates rather than new fab capital expenditures. Any selective wafer-start cuts or utilization pauses by major customers would immediately temper chemical replenishment rates.
• Customer Concentration: The company maintains heavy revenue dependency on Samsung Electronics. Pricing pressure during annual chemical contract renegotiations or delays in qualifying on next-generation sub-2nm/EUV layers could cap margin expansion.
• Overseas Execution Timelines: Slower-than-anticipated commercial production ramps at client facilities in North America could stretch pre-operating costs and weigh on return on invested capital (ROIC) in the near to medium term.

This note was produced by Chip & Cell’s data pipeline with model-assisted analysis. It is not investment advice; verify all figures against primary sources.

Not investment advice. Figures are as of publication and may contain errors — see methodology.